Brief: Larimar Therapeutics Q1 Net Income USD -14.654 Million
May 09 (Reuters) - Larimar Therapeutics Q1 income from operations USD -16.734 million. * Q1 basic EPS USD -0.27 * Q1 operating expenses USD 16.734 million
Recent news on Larimar Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
Larimar tumbles as safety concerns resurface in rare disease drug study update
U.S. STOCKS ON THE MOVE-Regenxbio, Repay, Natera, Fortune Brands
U.S. STOCKS ON THE MOVE-SpaceX, Charter, Gulfport Energy
Larimar tumbles as safety concerns resurface in rare disease drug study update